Results 231 to 240 of about 3,265,867 (293)

Efficacy and safety of indobufen- versus aspirin-based dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis. [PDF]

Ann Med Surg (Lond)
Khalid S, Khan K, Haris M, Khan K, Khan MQ, Khan MHA, Ahmad K, Alam I, Zahid SA, Aziz K, Ali S, Ronaq J, Rehman MEU, Hameed MS, Omarzai RG.   +14 more
europepmc   +1 more source

The effect of dual antiplatelet therapy in different patterns of watershed infarction: Subgroup analysis of the INSPIRES trial. [PDF]

Cell Rep Med
Liu C, Li Y, Liu Z, Gao Y, Zhang Q, Wabnitz AM, Pan Y, Yan H, Chen W, Johnston SC, Wang D, Amarenco P, Bath PM, Wang Y, Wang Y, Guan L.   +15 more
europepmc   +1 more source

Prophylactic tirofiban versus oral dual antiplatelet therapy in patients undergoing endovascular treatment of intracranial aneurysms: A meta-analysis. [PDF]

Medicine (Baltimore)
Miao Y, Li Q, Chen J, Liu Z.
europepmc   +1 more source

Real-world long-term outcomes of clopidogrel-based dual antiplatelet therapy post-drug-eluting stent implantation in all comers patients: A retrospective evaluation. [PDF]

Am Heart J Plus
Parikh R, Langade J, Langade D.
europepmc   +1 more source

Impact of dual antiplatelet therapy duration after percutaneous coronary intervention on outcomes in acute coronary syndrome patients with and without chronic kidney disease: a nationwide cohort study. [PDF]

Ren Fail
Chang KW, Liao PL, Huang JY.
europepmc   +1 more source